Abstract: Implementations set forth herein relate to systems, methods, and apparatuses associated with fullerene-containing materials. In some implementations, a fullerene-containing material is disposed over a substrate of a smoke-able product in order to inhibit an allergic response (e.g., coughing) from a user who smokes or otherwise ingests the smoke-able product. Various fullerene-containing materials can be generated using a carbon substance that undergoes one or more process operations in order for fullerene molecules to be available for inclusion in the various materials. In some implementations, one or more other fullerene-containing materials can be generated through an at least partially organic process of feeding a particular plant a fullerene-containing plant food.

Abstract: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.

Abstract: A rheofluidifying surfactant composition structured into planar lamellar phases includes: a) at least one anionic surfactant and b) at least one compound selected from among amphoteric surfactants and non-ionic surfactants, in which the total active material of said surfactants is between 35 and 60% by weight relative to the total weight of said composition, in which the ratio of anionic surfactant is between 0.3 and 0.9, the ratio of amphoteric surfactant is between 0.0 and 0.7 and the ratio of non-ionic surfactant is between 0.0 and 0.

Abstract: The present invention relates to a formulation that can be utilised to facilitate expression of natural behaviour in pigs, and in particular sows and weaners and a method which utilises the formulation for the same.

Abstract: Provided is a cosmetic having a unique soft and springy feeling in use, capable of stably formulating therein a UV protector, and providing a light feeling in use such that the cosmetic is separated into pieces when applied to the skin. The present invention relates to a cosmetic characterized by comprising (A) a (meth)acrylic acid/an alkyl (meth)acrylate/a (meth)acrylic acid-POE monoalkyl ether ester copolymer, (B) a UV protector, (C) a nonionic surfactant, and (D) a higher alcohol.

Abstract: Kits enabling an end user to efficiently compound inhalable formulations containing medicinal compounds, for use in in aerosol device (e-cigarette; personal vaporizer). Kits include a reusable storage device, a filling station, at least one predetermined amount aerosol precursor in a container and at least one empty cartomizer (cartridge) for use in an aerosol delivery device. Optionally, kits may also include a predetermined amount of extract containing a known amount of medicinal compound, enabling the production of an amount an inhalable formulation. Optionally, kits may contain amounts of inputs that enable the refilling/reuse of cartridges.

Abstract: Process for conferring a protection against a pathogen upon a plant by elicitation by an aqueous composition, the active agents of which are extracted from edible fungi (parasol mushroom, pleurotus, button mushroom). An alkaline extraction is carried out, then an enzymatic hydrolysis, to obtain a fraction less than 100 kDa. The process consists in spraying the aerial parts of the plant with the composition obtained in this way; this thereby acts to combat cryptogamic diseases of plants such as vines, fruit trees, vegetable crops and cereals.

Abstract: Embodiments of the present disclosure generally relate to coated substrates having, e.g., anti-viral properties, to articles including the coated substrates, and to processes for making such coated substrates and articles. In an embodiment, a mask for preventing infection by a virus is provided. The mask includes a coated substrate having a breathing resistance (95 L/min, EN 149:2001) of about 6 mbar or less and a water droplet absorption time of less than about 5 seconds. The coated substrate includes a non-woven fabric having a weight of about 120 g/m2 or less according to ASTM D3776, and mineral oxide particles, iron oxide particles, or both, coupled to at least a portion of the non-woven fabric.

Abstract: The present invention relates to herbicidal) active pyridyl-/pyrimidyl-pyrazine derivatives, as well as to processes and intermediates used for the preparation of such derivatives. The invention further extends to herbicidal compositions comprising such derivatives, as well as to the use of such compounds and compositions in controlling undesirable plant growth: in particular the use in controlling weeds, in crops of useful plants.

Abstract: The present disclosure relates a method of treating chondrosarcoma or suppressing metastasis or recurrence thereof by regulating HIF-2?. The present method can be effectively used for treating chondrosarcoma or suppressing metastasis or recurrence thereof by inhibiting HIF-2? during the development and metastasis of chondrosarcoma, particularly dedifferentiated chondrosarcoma.

Abstract: An antimicrobial composition is provided that comprises about 10.0 to about 40.0 wt. % of one or more C1-8 alcohols, based on the total weight of the antimicrobial composition; and two or more of a surfactant; an enhancer; and a buffer. The pH of the composition is less than or equal to about 6.0 and the composition achieves a microbial log reduction of greater than 4.0 log CFU/ml at a contact time of 1 minute, in accordance ASTM E2783.

Abstract: Self-assembled gel compositions including a gelator, e.g., an enzyme-cleavable gelator, e.g., having a molecular weight of 2500 or less, are described. The self-assembled gel compositions can encapsulate one or more agents. Methods of making the self-assembled gel compositions, and methods of drug delivery using the self-assembled gel compositions are also described.

Abstract: Presently disclosed is a high load glyphosate herbicidal composition with high efficiency and low toxicity. The composition includes glyphosate as a mixture of potassium salts and glyphosate salt with monoisopropylamine (MIPA) of a glyphosate (acid equivalent) load of 400 to 600 g/L in balance with a surfactant system formed by an oxidized amine, an aliphatic alcohol, and a complexing agent, for the control of weeds in agricultural crops. The composition further includes adjuvants which promote a significantly more advantageous herbicidal efficacy than other known glyphosate formulations.

Abstract: The present invention relates to anti-inflammatory drug formulation. Especially, this invention relates to corticosteroid prodrug nanoparticle. In a first aspect, this invention relates to a nanoparticle comprising a therapeutic agent and a surface coating material. The invention also relates to a process of manufacturing at least one nanoparticle of invention. The invention also relates to pharmaceutical composition and pharmaceutical kits.

Abstract: The present invention relates to compositions and methods for increasing tolerance to abiotic stress and/or for reducing the consequence of abiotic stress in a plant and/or part thereof. In some aspects, the method comprises contacting a plant and/or part thereof with a first composition comprising one or more of aminoguanidine, L-nitroarginine, L-nitroarginine methyl ester, 2,2?-bipyridine, 4-methylpyrazole, 8-hydroxyquiniline, caprylic acid, pyrazole, naringenin, kaempferol, quercetin, dodecanoic acid, and/or undecanoic acid, and/or a salt thereof; and a second composition comprising at least one dicarboxylic acid and/or a salt thereof.

Abstract: This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an ?-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate.

Abstract: The present invention includes CSNK1A1 inhibitors that are useful in treating or preventing a cancer in a subject. In certain embodiments, the cancer comprises a hematological cancer, such as but not limited to acute myeloid leukemia (AML) and/or MDS (myelodysplastic syndrome, including 5q-MDS). In other embodiments, the cancer comprises colon cancer.

Abstract: The instant invention describes an anti-biofouling structure for placement onto structures or surfaces that are exposed to aquatic environments. Embedded within the anti-biofouling structure are agents that can diffuse out of the structure and prevent the formation and/or accumulation of plant and animal species build-up that creates biofouling. The instant invention also describes a system for preventing biofouling of an object stored in an aquatic environment which includes the anti-biofouling structure, and a protective cover element constructed and arranged to fit various structures, such as boat propellers.

Abstract: A drug composition in a liquid form sealed within a soft capsule containing succinylated gelatin as a principal component thereof, the composition including (a) one kind of phenol derivative or a mixture of multiple kinds thereof and (b) a succinylated-gelatin insolubilizing agent; and a soft capsule drug including a capsule shell containing succinylated gelatin as a principal component thereof, the shell sealing therein a drug composition in a liquid form including (a) one kind of phenol derivative or a mixture of multiple kinds thereof; and (b) a succinylated-gelatin insolubilizing agent.

Abstract: The invention relates to pyrrolone compounds of the formula (I) wherein X, R1, R2, R3, Ra, Rb, Rc and Rd are as defined in the specification. Furthermore, the present invention relates to processes and intermediates for making compounds of formula (I), to herbicidal compositions comprising these compounds and to methods of using these compounds to control plant growth.